Statistics for GenSight Biologics SA (id:10968 SIGHT)
Valuation metrics
Market cap
35.75M
Enterprise value
47.33M
Trailing P/E (ttm)
-0.61
Forward P/E
-0.46
PEG ratio
-0.46
Price/Sales (ttm)
18.09
Price/Book (mrq)
Enterprise Value/Revenue
23.95
Enterprise Value/EBITDA
-2.46
Overview
Shares outstanding
115.16M
Float
39.11M
Shares short
% Held by insiders
0.13%
% Held by institutions
0.19%
Average volume (10 days)
450.69K
Average volume (90 days)
Price summary
52-Week low
0.28
52-Week high
0.60
52-Week change
-57.69%
Beta
2.33
50-Day moving average
0.34
200-Day moving average
0.37
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
December 31th, 2023
Profitability
Profit margin
0.00%
Operating margin
-428.41%
Operational effectiveness
Return on assets
-78.84%
Return on equity
85.50%
Income statement
Revenue (ttm)
0.03
Revenue per share (ttm)
0.03
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-19,212,000.00
Net income to common (ttm)
-20,106,000.00
Diluted EPS (ttm)
-0.35
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
6.94M
Total cash per share (mrq)
0.07
Total debt (mrq)
22.68M
Total Debt/Equity (mrq)
-0.74
Current ratio (mrq)
77.20%
Book value per share (mrq)
-0.24
Cash flow
Cash flow statement
-15,800,000.00
Levered free cash flow (LFCF)
-8,391,375.00